Page 35 - Read Online

aging. Clin Interv Aging 2008;3:153-9. 58. Jansen DA, Graivier MH. Evaluation of calcium hydroxylapatite based
30. Mansouri Y, Goldenberg G. Update on hyaluronic acid fillers for facial implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg
rejuvenation. Cuti 2015;96:85-8. 2006;118:S22-30.
31. Pollack SV. Some new injectable dermal filler materials: Hylaform, Restylane 59. Ahn MS. Calcium hydroxylapatite: Radiesse. Facial Plast Surg Clin North Am
and Artecoll. J Cutan Med Surg 1999;Suppl 4:S27-35. 2007;15:85-90.
32. Rongioletti F, Cattarini G, Sottofattori E, Rebora A. Granulomatous 60. Duffy DM. Complications of fillers. Overview. Dermatol Surg 2005;31:1626-
reaction after intradermal injections of hyaluronic acid gel. Arch Dermatol 33.
2003;139:815-6. 61. Beer KR. Radiesse nodule of the lips from a distant injection site: report
33. Shafir R, Amir A, Gur E. Long-term complications of facial injections with of a case and consideration of etiology and management. J Drugs Dermatol
Restylane (injectable hyaluronic acid). Plast Reconstr Surg 2000;106:1215-6. 2007;6:846-7.
34. Dal Sacco D, Cozzani E, Parody A, Rebora A. Scar sarcoidosis after hyaluronic 62. Kim JA, Van Abel D. Neocollagenesis in human tissue injected with a
acid injection. Int J Dermatol 2005;44:411-2. polycaprolactone-based dermal filler. J Cosmet Laser Ther 2015;17:99-101.
35. Descamps V, Landry J, Frances C, Marinho E, Ratziu V, Chosidow O. Facial 63. Moers-Carpi MM, Sherwood S. Polycaprolactone for the correction of
cosmetic filler injections as possible target for systemic sarcoidosis in nasolabial folds: a 24-month, rospective, randomized, controlled clinical trial.
patients treated with interferon for chronic hepatitis C: two cases. Dermatol Dermatol Surg 2013;39:457-63.
2008;217:81-4. 64. Figueiredo VM. A five-patient prospective pilot study of a polycaprolactone
36. Schanz S, Schipper W, Ulmer A, Rassner G, Fierlbeck G. Arterial embolization based dermal filler for hand rejuvenation. J Cosmet Dermatol 2013;12:73-7.
caused by injection of hyaluronic acid (Restylane). Br J Dermatol 2002;146:928- 65. Nicolau PJ, Marijnissen-Hofsté J. Neocollagenesis after injection of a
9. polycaprolactone based derma filler in a rabbit. Eur J Aesth Med Dermatol
37. Grossman KL. Hyaluronic acid gel fillers: hypersensitivity reactions. Aesthet 2013;3:19-26.
Surg J 2005;25:403-5. 66. Leonardis M, Palange A. New-generation filler based on cross-linked
38. Leonard JM, Lawrence N, Narin RS. Angioedema acute hypersensitivity carboxymethylcellulose: study of 350 patients with 3-year follow-up. Clin
reaction to injectable hyaluronic acid. Dermatol Surg 2005;31:577-9. Interv Aging 2015;10:147-55.
39. Schierle CF, Casas LA. Nonsurgical rejuvenation of the aging face with 67. Leonardis M, Palange A, Dornelles RF, Hund F. Use of cross-linked
injectable poly-L-lactic acid for storation of soft tissue volume. Aesthet Surg J carboxymethyl cellulose for soft-tissue augmentation: preliminary clinical
2011;31:95-109. studies. Clin Interv Aging 2010;5:317-22.
40. Ladewig K, Abberton K, Andrea J O’Connor. Designing in vivo bioreactors for 68. Neuber F. Fettransplantation. Chir Kongr Verhandl Dsch Gesellch Chir
soft tissue engineering. J Biomater Tissue Engineering 2012;2:1-13. 1893;22:66.
41. Gogolewski S, Jovanovic M, Perren SM, Dilon JG, Hughes MK. Tissue 69. Cervelli V, Palla L, Pascali M, De Angelis B, Curcio BC, Gentile P. Autologous
response and in vivo degradation of selected poly-hydroxyacids: polylactides platelet-rich plasma mixed with purified fat graft in aesthetic plastic surgery.
(PLA), poly(3-hydroxybutyrate) (PHB) and poly(3-hydroxybutyrate-co-3- Aesthetic Plast Surg 2009;33:716-21.
hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993;27:1135-48. 70. Sterodimas A, De Faria J, Nicaretta B, Papadopoulos O, Papalambros E, Illouz
42. Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): YG. Cell-assisted lipotransfer. Aesthet Surg J 2010;30:78-81.
technical considerations in soft-tissue contouring. Plast Reconstr Surg 71. Ersek RA. Transplantation of purified autologous fat: a 3-year follow-up is
2006;118:S55-63. disappointing. Plast Reconstr Surg 1991;87:219-27.
43. Vleggaar D. Facial volumetric correction with injectable poly-L-lactic acid. 72. Coleman SR. Long-term survival of fat transplants: controlled demonstrations.
Dermatol Surg 2005;31:1511-7. Aesthetic Plast Surg 1995;19:421-5.
44. Vleggaar D, Bauer U. Facial enhancement and the European experience with 73. Fulton JE, Suarez M, Silverton K, Barnes T. Small volume fat transfer. Dermatol
Sculptra (poly-L-lactic acid). J Drugs Dermatol 2004;3:542-7. Surg 1998;24:857-65.
45. Athanasiou KA, Niederauer GG, Agrawal CM, Landsman AS. Applications 74. Fournier PF. Fat grafting: my technique. Dermatol Surg 2000;26:1117-28.
of biodegradable lactides and glycolides in podiatry. Clin Podiatr Med Surg 75. Kanchwala SK, Bucky LP. Facial fat grafting: the search for predictable results.
1995;12:475-95. Facial Plast Surg 2003;19:137-46.
46. Spenlehauer G, Vert M, Benoit JP, Boddaert A. In vitro and in vivo degradation of 76. Cheng JT, Perkins SW, Hamilton MM. Collagen and injectable fillers.
poly(D, L-lactide/glycolide) acid microspheres made by solvent evaporation Otolaryngol Clin North Am 2002;35:73-85.
method. Biomater 1989;10:557-63. 77. Carruthers JD, Fagien S, Rohrich RJ, Weinkle S, Carruthers A. Blindness
47. Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plast caused by cosmetic filler injection: a review of cause and therapy. Plast
Reconstr Surg 2006;118:S46-54. Reconstr Surg 2014;134:1197-201.
48. Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen 78. Hong DK, Seo YJ, Lee JH, Im M. Sudden visual loss and multiple cerebral
H, Bousquet R, Katz P, Costagliola D, Katama C. Polylactic acid implants infarction after autologous fat injection into the glabella. Dermatol Surg
(New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of 2014;40:485-7.
the open-label study. AIDS 2003;17:2471-7. 79. Yamauchi PS. Emerging permanent filler technologies: focus on aquamid. Clin
49. Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler Cosmet Investig Dermatol 2014;7:261-6.
complications. Plast Reconstr Surg 2006;118:S92-107. 80. Peters W, Fornasier V. Complications from injectable materials used for
50. Alijotas-Reig J, Fernández-Figueras MT, Puig L. Inflammatory, immune- breast augmentation. Can J Plast Surg 2009;17:89-96.
mediated adverse reactions related to soft tissue dermal fillers. Semin 81. Altmeyer MD, Anderson LL, Wang AR. Silicone migration and granuloma
Arthritis Rheum 2013;43:241-58. formation. J Cosmet Dermatol 2009;8:92-7.
51. Fan M, Liao J, Guo G, Ding Q, Yang Y, Luo F, Qian Z. Dexamethasone- 82. Schwartzfarb EM, Hametti JM, Romanelli P, Ricotti C. Foreig body granuloma
loaded poly (D,L-lactic acid) microspheres/poly (ethylene glycol) = poly formation secondary to silicone injection. Dermatol Online J 2008;14:20.
(epsilon-caprolactone) – poly (ethylene glycol) micelles composite for skin 83. Ficarra G, Mosqueda-Taylor A, Carlos R. Silicone granuloma of the facial
augmentation. J Biomed Nanotechnol 2014;10:592-602. tissues: a report of seven cases. Oral Surg Oral Med Oral Pathol Oral Radiol
52. Lafaurie M, Dolivo M, Porcher R, Rudant J, Madelaine I, Molina JM. Treatment Endod 2002;94:65-73.
of facial lipoatrophy with intradermal injections of polylactic acid in HIV- 84. Schmid A, Tzur A, Leshko L, Krieger BP. Silicone embolism syndrome: a
infected patients. J Acquir Immune Defic Syndr 2005;38:393-8. case report, review of the literature, and comparison with fat embolism
53. Tzikas TL. Evaluation of the radiance FN soft tissue filler for facial soft tissue syndrome. Chest 2005;127:2276-81.
augmentation. Arch Facial Plast Surg 2004;6:234-9. 85. Vent J, Lemperle G. Prevention and treatment of complications after
54. Marmur ES, Phelps R, Goldberg DJ. Clinical, histologic and electron polymethylmethacrylate-microspheres injections. Facial Plast Surg
microscopic findings after injection of a calcium hydroxylapatite filler. J 2014;30:628-34.
Cosmet Laser Ther 2004;6:223-6. 86. Lemperle G, Nacul AM, Fortes FB. Can injection of PMMA-microspheres
55. Broder KW, Cohen SR. An overview of permanent and semipermanent cause hypercalcemia? Clin Cases Miner Bone Metab 2015;12:82-3.
fillers. Plast Reconstr Surg 2006;118:7S-14S. 87. Bachmann F, Erdmann R, Hartmann V, Becker-Wegerich P, Wiest L, Rzany B.
56. Silvers SL, Eviatar JA, Echavez MI, Pappas AL. Prospective, open-label, Adverse reactions caused by consecutive injections of different fillers in the
18-month trial of calcium hydroxylapatite (Rad-iesse) for facial soft-tissue same facial region: risk assessment based on the results from the injectable
augmentation in patient with human immunodeficiency virus-associated filler safety study. J Eur Acad Dermatol Venereol 2011;25:902-12.
lipoatrophy: one-year durability. Plast Reconstr Surg 2006;118:S34-45. 88. Limongi RM, Tao J, Borba A, Pereira F, Pimentel AR, Akaishi P, Velasco E Cruz
57. Sklar JA, White SM. Radiance FN: a new soft tissue filler. Dermatol Surg AA. Complications and management of polymethylmethacrylate (PMMA)
2004;30:764-8. injections to the midface. Aesthet Surg J 2016;36:132-5.
98 Plast Aesthet Res || Vol 3 || Mar 23, 2016